Literature DB >> 11524416

Demethylase activity is directed by histone acetylation.

N Cervoni1, M Szyf.   

Abstract

Mammalian genomes are compartmentalized into dense inactive chromatin that is hypermethylated and active open chromatin that is hypomethylated. It is generally accepted that this bimodal pattern of methylation is established during development and is then faithfully inherited through subsequent cell divisions by a maintenance DNA methyltransferase (DNMT1). The pattern of methylation is believed to direct local histone acetylation states. In contrast to this well accepted consensus, we show here using a transient transfection model that an active demethylase is involved in shaping patterns of methylation in somatic cells. Demethylase activity is directed by the state of histone acetylation, and therefore, the resulting methylation pattern is determined by local histone acetylation states contrary to the accepted model. Our data support a new model suggesting that the pattern of methylation is maintained by a dynamic balance of methylation and demethylation activities and the local state of histone acetylation. This provides a simple mechanism for explaining why active genes are not methylated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524416     DOI: 10.1074/jbc.M103921200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  A multistep mechanism for the activation of rearrangement in the immune system.

Authors:  Yanhong Ji; Jianmin Zhang; Alfred Ian Lee; Howard Cedar; Yehudit Bergman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-11       Impact factor: 11.205

2.  Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription.

Authors:  Manuela Rehtanz; Hanns-Martin Schmidt; Ursula Warthorst; Gertrud Steger
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 3.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

4.  Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine.

Authors:  Kyung Hyun Choi; Hesham Basma; Jaswant Singh; Pi-Wan Cheng
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

5.  Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy.

Authors:  Hiroyoshi Iseki; Rie Shimizukawa; Fumihiro Sugiyama; Satoshi Kunita; Atsushi Iwama; Masafumi Onodera; Hiromitsu Nakauchi; Ken-ichi Yagami
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 6.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

7.  Epigenetic programming of the rRNA promoter by MBD3.

Authors:  Shelley E Brown; Moshe Szyf
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

8.  Epigenetics in mood disorders.

Authors:  Patrick O McGowan; Tadafumi Kato
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

9.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.

Authors:  Patrick O McGowan; Aya Sasaki; Ana C D'Alessio; Sergiy Dymov; Benoit Labonté; Moshe Szyf; Gustavo Turecki; Michael J Meaney
Journal:  Nat Neurosci       Date:  2009-03       Impact factor: 24.884

10.  Expression Profiles of SIRT1 and APP Genes in Human Neuroblastoma SK-N-SH Cells Treated with Two Epigenetic Agents.

Authors:  Yaping Hou; Fanghua Wang; Linping Cheng; Tao Luo; Jie Xu; Huaqiao Wang
Journal:  Neurosci Bull       Date:  2016-08-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.